#ESMO21 Pembrolizumb/CT will be the new standard in high-risk TNBC. Well… but does one size fits all? #PrecisionImmumology is a major unmet need Find out more on LBA12 and read the today Daily Reporter @myESMO @mauricallari Tweet added by Giampaolo Bianchini @BianchiniGP | Musk Viewer

@BianchiniGP

Giampaolo Bianchini

3 years

#ESMO21 Pembrolizumb/CT will be the new standard in high-risk TNBC. Well… but does one size fits all? #PrecisionImmumology is a major unmet need Find out more on LBA12 and read the today Daily Reporter @myESMO @mauricallari

@myESMO

ESMO - Eur. Oncology

3 years

#Immuno -oncology score predicts response to atezolizumab in #TNBC : Results from an exploratory post-hoc analysis of the NeoTRIPaPDL1 study 👉 #ESMO21 Daily Reporter #bcsm #breastcancer #immunotherapy #tcell

Tweet media one

0

9

19

1

12

32

Replies

@drtimrobinson

Tim Robinson

3 years

@BianchiniGP @myESMO @mauricallari Very nice presentation and results

0

0

3